C61H72N16O5 — CID 137361980
2-(6-piperazin-1-ylpyridazin-3-yl)-5-pyrazol-1-ylphenol;5-pyrazol-1-yl-2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]phenol;5-(1H-pyrazol-4-yl)-2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]phenol (PubChem CID 137361980) has the molecular formula C61H72N16O5 and a molecular weight of 1109.35 g/mol. Its IUPAC name is 2-(6-piperazin-1-ylpyridazin-3-yl)-5-pyrazol-1-ylphenol;5-pyrazol-1-yl-2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]phenol;5-(1H-pyrazol-4-yl)-2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]phenol.
| Compound Name | 2-(6-piperazin-1-ylpyridazin-3-yl)-5-pyrazol-1-ylphenol;5-pyrazol-1-yl-2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]phenol;5-(1H-pyrazol-4-yl)-2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]phenol |
|---|---|
| PubChem CID | 137361980 |
| Molecular Formula | C61H72N16O5 |
| Molecular Weight | 1109.35 g/mol |
| Exact Mass | 1108.59 |
| IUPAC Name | 2-(6-piperazin-1-ylpyridazin-3-yl)-5-pyrazol-1-ylphenol;5-pyrazol-1-yl-2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]phenol;5-(1H-pyrazol-4-yl)-2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]phenol |
| SMILES | CC1(C)CC(Oc2ccc(-c3ccc(-c4cn[nH]c4)cc3O)nn2)CC(C)(C)N1.CC1(C)CC(Oc2ccc(-c3ccc(-n4cccn4)cc3O)nn2)CC(C)(C)N1.Oc1cc(-n2cccn2)ccc1-c1ccc(N2CCNCC2)nn1 |
| InChI | InChI=1S/2C22H27N5O2.C17H18N6O/c1-21(2)13-16(14-22(3,4)26-21)29-20-9-8-18(24-25-20)17-7-6-15(12-19(17)28)27-11-5-10-23-27;1-21(2)10-16(11-22(3,4)27-21)29-20-8-7-18(25-26-20)17-6-5-14(9-19(17)28)15-12-23-24-13-15;24-16-12-13(23-9-1-6-19-23)2-3-14(16)15-4-5-17(21-20-15)22-10-7-18-8-11-22/h5-12,16,26,28H,13-14H2,1-4H3;5-9,12-13,16,27-28H,10-11H2,1-4H3,(H,23,24);1-6,9,12,18,24H,7-8,10-11H2 |
| InChIKey | LBIPWGZDCDNNMT-UHFFFAOYSA-N |
| XLogP | 9.09 |
| TPSA | 260.14 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 20 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 82 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1109.35 |
| LogP ≤ 5 | 9.09 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 20 |